Download PDF
Deutsche Zeitschrift für Onkologie 2012; 44(2): 72-75
DOI: 10.1055/s-0032-1314667
Praxis
© Karl F. Haug Verlag MVS Medizinverlage Stuttgart GmbH & Co. KG

Elektrolytveränderungen aus der Sicht des Palliativmediziners

Jens Büntzel
,
Heike Büntzel
,
Oliver Micke
,
Ralph Mücke
,
Klaus Kisters
*   für den Arbeitskreis „Trace Elements and Electrolytes in Oncology“ (AKTE)
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2012 (online)

    Permissions and Reprints

Zusammenfassung

In den letzten Lebensmonaten weisen drei Viertel aller Patienten Veränderungen des Elektrolythaushaltes auf. Nicht alle von ihnen haben eine klinische Relevanz, lediglich 30 % aller Patienten benötigen eine Behandlung dieser Laborveränderungen. An Hand von vier Kasuistiken wird die klinische Leitsymptomatik der Hyponatriämie, der Hypokaliämie, der Hyperkaliämie und der Hypomagnesiämie dargestellt. Symptomatische Behandlungsansätze sollten in der Palliativsituation im Vordergrund stehen und werden deshalb gezielt diskutiert.

Summary

During the last month of life 75 % of all patients will show changes of electrolyte’s in blood. Only few of them have a clinical importance. Nearly a third of all patients have to be treated because of electrolytic changes. Four case histories should present the important clinical signs of hyponatremie, hypokalemia, hyperkalemia and hypomagnesemia during the end of life. From our point of view therapy should be restricted to a minimum. Symptomatic treatment approaches should be preferred because of the end-of-life situation.

Schlüsselwörter

Elektrolyte - Onkologie - Kasuistik - Hyponatriämie - Hypokaliämie - Hyperkaliämie - Hypomagnesiämie

Keywords

Electrolytes - oncology - case report - hyponatremie - hypokalemia - hyperkalemia - hypomagnesemia
 

  • Literatur

  • 1 Baretta Z, Ghiotto C, Marino D, Jirillo A. Aloe-induced hypokalemia in a patient with breast cancer during chemotherapy. Ann Oncol 2009; 20: 1445-1446
    PubMedGoogle Scholar
  • 2 Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer 1996; 4: 341-350
    CrossrefPubMedGoogle Scholar
  • 3 Bundesministerium für Ernährung, Landwirtschaft und Verbraucherschutz. Nationale Verzehrsstudie II. Ergebnisbericht. Teil 2. Max Rubner-Institut; 2008 http://www.was-esse-ich.de/uploads/media/NVSII_Abschlussbericht_Teil_2.pdf
    PubMedGoogle Scholar
  • 4 Elsayem A, Mori M, Parsons HA, Munsell MF, Hui D, Delgado-Guay MO, Paraskevopoulos T, Fadul NA, Bruera E. Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center. Support Care Cancer 2010; 18: 67-76
    PubMedGoogle Scholar
  • 5 Fakih MG, Wilding G, Lombardo J. Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Clin Colorectal Cancer 2006; 6: 152-156
    CrossrefPubMedGoogle Scholar
  • 6 Kamel KS, Wie C. Controversial issues in the treatment of hyperkalaemia. Nephrol Dial Transplant 2003; 18: 2215-2218
    CrossrefPubMedGoogle Scholar
  • 7 Langfeldt LA, Cooley ME. Syndrome of inappropriate hormone secretion in malignancy: review and implications for nursing management. Clin J Oncol Nurs 2003; 7: 425-430
    CrossrefPubMedGoogle Scholar
  • 8 Liebscher DH, Liebscher DE. About the misdiagnosis of magnesium deficiency. J Amer Coll Nutr 2004; 23: 730-31
    PubMedGoogle Scholar
  • 9 Marinella MA. Refeeding syndrome: an important aspect of supportive oncology. J Support Oncol 2009; 7: 11-16
    PubMedGoogle Scholar
  • 10 Michallet AS, Tartas S, Coiffier B. Optimizing management of tumor lysis syndrome in adults with hematologic malignancies. Support Cancer Ther 2005; 2: 159-166
    CrossrefPubMedGoogle Scholar
  • 11 Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 2007; 15: 1341-1347
    CrossrefPubMedGoogle Scholar
  • 12 Rastergar A, Soleimani M. Hypokalaemia and hyperkalaemia. Postgrad Med J 2001; 77: 759-764
    CrossrefPubMedGoogle Scholar
  • 13 Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 2001; 14: 283-290
    Google Scholar
  • 14 Smith HM, Farrow SJ, Ackerman JD, Stubbs JR, Sprung J. Cardiac arrests associated with hyperkalemia during red blood cell transfusion: a case series. Anesth Analg 2008; 106: 1062-1069
    CrossrefPubMedGoogle Scholar
  • 15 Sorensen JB, Andersen MK, Hansen HH. Syndrome of inapporpriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 1995; 238: 97-110
    CrossrefPubMedGoogle Scholar